SNCA and Parkinson disease: Although we cannot discern whether the synergy between α-synuclein overexpression and LPS-induced inflammation is limited to an acceleration of PD-like symptoms typically expressed at later stages in Snca+/+ rats or exacerbates their expression, experiments performed at later stages of LPS injection are needed to clarify this problem.